Researchers find genetic fingerprints to predict efficacy of immunotherapy
Israeli researchers have identified a genetic "fingerprint" that helps predict the effectiveness of immunotherapy treatments, according to a study.
The study, by the Israel Institute of Technology (Technion), stated that the discovery would help improve the personalisation of immunotherapy treatments, Xinhua news agency reported.
Immunotherapy is considered to be one of the greatest revolutions in cancer treatment. It enhances the immune system's ability to target and destroy cancer cells efficiently.
However, a major challenge in immunotherapy is the unpredictability of patient responses. Some patients do not benefit and may experience side effects without significant improvement.
Therefore, there is a need to identify biomarkers that can forecast the effectiveness of treatment based on the specific data of each patient.
In their study, published in the journal Cell Genomics, the team examined the genetic characteristics of T-cell clones -- groups of multiplied immune T cells that specialise in targeting a specific threat once recognised -- and their influence on treatment success.
To achieve the goal, the team conducted a large-scale meta-analysis using single-cell RNA sequencing and T-cell receptor sequencing data from cancer patients undergoing immunotherapy.
It was found that although these T-cell clones are present in both responsive and non-responsive patients, those who respond to immunotherapy display a distinct genetic signature in their T-cell clones, and the treatment boosts their immune activity.
Another major finding was that in non-responsive patients, some T-cell clones were simultaneously found both in the bloodstream and the tumour.
To achieve a better immune response, it is crucial to activating T-cell clones located solely within the tumour, rather than those present in both the tumour and the bloodstream, the researchers said.
They added that this discovery will enhance predictive capabilities and could lead to new treatment strategies that improve the effectiveness of immunotherapy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
6 hours ago
- Hans India
Vietnam's capital reports 150 new Covid-19 cases in past week
Hanoi: Vietnamese capital Hanoi confirmed 150 new Covid-19 cases in the city from May 30 to June 6, slightly down from the previous week, reports said. Since the beginning of 2025, the capital city has recorded 558 infections, a decrease of 109 cases compared to the same period last year, the report said. The Hanoi Centre for Disease Control has requested local units to strengthen public communication on Covid-19 and other seasonal diseases, Xinhua news agency reported, citing the Vietnam News Agency. Meanwhile, Covid cases are once again on the rise in India, with 5,364 active cases currently reported and four deaths recorded in the last 24 hours. Since January 1, more than 4,700 people in India have recovered from the virus, while 55 fatalities have been reported during this period. The primary driver of the recent surge is a new coronavirus variant known as NB.1.8.1, a subvariant of Omicron. This strain has been detected in several countries, including the United Kingdom, the United States, Australia, Thailand, China, and Hong Kong. NB.1.8.1 was first identified in January 2025 and is classified as a "recombinant" variant—meaning it emerged through the genetic mixing of two or more previous strains. On May 23, 2025, the World Health Organisation (WHO) designated NB.1.8.1 as a "Variant Under Monitoring" (VUM). According to the WHO's 2023 definition, a VUM is a variant that has undergone genetic changes that may affect the virus's characteristics. Early data suggests that NB.1.8.1 may spread more easily or grow faster than other variants, though this has yet to be confirmed. The impact of NB.1.8.1 on health, immunity, and transmission is still being studied. However, lab-based models indicate that the strain binds more efficiently to human cell receptors, suggesting it may infect cells more effectively than earlier variants. Common symptoms associated with NB.1.8.1 include sore throat, cough, fever, muscle aches, and nasal congestion. Some patients also report gastrointestinal symptoms such as nausea and diarrhoea. Despite the emergence of this new strain, health experts emphasise that vaccines continue to offer strong protection against infection, severe illness, hospitalisation, and death.
Hans India
11 hours ago
- Hans India
Researchers develop brain training game for chronic nerve pain
New Delhi: Australian researchers have developed a new interactive game, showing early promise as a non-invasive, drug-free alternative for managing chronic nerve pain. The project, called PainWaive, trains users to regulate abnormal brain activity linked to neuropathic pain, Xinhua news agency reported. Developed by researchers from the University of New South Wales (UNSW), the game uses a headset to monitor brainwaves in real time while players engage with a mobile game that rewards healthy brainwave patterns, offering a potential home-based replacement for painkillers such as opioids. Three out of four participants reported significant pain reduction after four weeks of use in a recent trial. Their relief was comparable to or greater than what is typically achieved with opioid medication, the team found. The game is based on disrupted brainwave activity in people with nerve pain, particularly changes in the thalamus -- a key relay centre in the brain. The technology helps users retrain abnormal brain activity using mental strategies like relaxation or positive imagery, said Sylvia Gustin, professor at UNSW. The findings are published in the Journal of Pain. 'Participants felt empowered to manage their pain in their own environment. That's a huge part of what makes this special,' said Dr Negin Hesam-Shariati from UNSW's NeuroRecovery Research Hub. Participants used a low-cost EEG (electroencephalogram) headset and tablet-based game at home, with remote monitoring by researchers. Designed using 3D printing and open-source parts, the headset costs around $193.7, far cheaper than commercial systems, and uses wet electrodes to target the brain's sensorimotor cortex for accurate pain-related readings, PainWaive's design prioritises accessibility for those with limited access to conventional treatments, Gustin said. She added that recruitment is underway for two larger trials targeting chronic spinal pain and neuropathic pain from spinal cord injuries.
&w=3840&q=100)
Business Standard
12 hours ago
- Business Standard
Israel claims warning shots fired after 12 killed in fire in Palestine
At least 108 bodies were brought to hospitals in Gaza over the past 24 hours. Israel's military said it struck dozens of militant targets throughout Gaza over the past day AP Deir al-Balah (Gaza Strip) Israeli fire killed at least 12 people and wounded others as they headed toward two aid distribution points in the Gaza Strip run by an Israeli and US-backed group, Palestinian health officials and witnesses said Sunday. Israel's military said it fired warning shots at people who approached its forces. The past two weeks have seen frequent shootings near the new hubs where thousands of Palestinians desperate after 20 months of war are being directed to collect food. Witnesses say nearby Israeli troops have opened fire, and more than 80 people have been killed, according to Gaza hospital officials. In all, at least 108 bodies were brought to hospitals in Gaza over the past 24 hours, the territory's Health Ministry said. Israel's military said it struck dozens of militant targets throughout Gaza over the past day. Eleven of the latest bodies were brought to Nasser Hospital in the southern city of Khan Younis. Palestinian witnesses said Israeli forces fired on some at a roundabout around a kilometre from a site run by the Gaza Humanitarian Foundation, or GHF, in nearby Rafah. Israel's military said it fired warning shots at approaching suspects who ignored warnings to turn away. It said the shooting happened in an area that is considered an active combat zone at night. Al-Awda Hospital said it received the body of a man and 29 people who were wounded near another GHF aid distribution point in central Gaza. The military said it fired warning shots in the area at around 6:40 am, but didn't see any casualties. A GHF official said there was no violence in or around its distribution sites, all three of which delivered aid on Sunday. The group closed them temporarily last week to discuss safety measures with Israel's military and has warned people to stay on designated access routes. The official spoke on condition of anonymity in line with regulations. The new aid hubs are set up inside Israeli military zones where independent media have no access. The GHF also said it was piloting direct delivery to a community north of Rafah. Witnesses fear for their safety Witnesses said the first shootings in southern Gaza took place at around 6 a.m., when they were told the site would open. Many headed toward it early, seeking desperately needed food before crowds arrived. Gaza's roughly 2 million Palestinians are almost completely reliant on international aid because nearly all food production capabilities have been destroyed. Adham Dahman, who was at Nasser Hospital with a bandage on his chin, said a tank fired toward them. We didn't know how to escape," he said. "This is trap for us, not aid. Zahed Ben Hassan said someone next to him was shot in the head. They said it was a safe area from 6 am until 6 pm... So why did they start shooting at us? he said. There was light out, and they have their cameras and can clearly see us. The military announced on Friday that the sites would be open during those hours, and the areas would be a closed military zone the rest of the time. Children cried over their father's body at the hospital. I can't see you like this, Dad! one girl said. Aid distributed inside Israeli military zones The new aid hubs are run by GHF, a new group of mainly American contractors. Israel wants it to replace a system coordinated by the United Nations and international aid groups. Israel and the United States accuse the Hamas militant group of stealing aid. The UN denies there is systematic diversion. The UN says the new system is unable to meet mounting needs, allows Israel to use aid as a weapon by determining who can receive it and forces people to relocate to where aid sites are positioned. The UN system has struggled to deliver aid, even after Israel eased its blockade of Gaza last month. UN officials say their efforts are hindered by Israeli military restrictions, the breakdown of law and order and widespread looting. Experts warned earlier this year that Gaza was at critical risk of famine, if Israel didn't lift its blockade and halt its military campaign. Both were renewed in March. Israeli officials have said the offensive will continue until all hostages are returned and Hamas is defeated or disarmed and sent into exile. On Sunday, Israel's military invited journalists into Khan Younis to show a tunnel under the European Hospital, saying they found the body of Mohammed Sinwar, the head of Hamas' armed wing, there after he was killed last month. Israel has barred international journalists from entering Gaza independently since the war began. (Israeli forces) would prefer not to hit or target hospitals, army spokesperson Brig. Gen. Effie Defrin said. Sinwar's body was found in a room under the hospital's emergency room, Defrin said. Hamas has said it will only release the remaining hostages in return for Palestinian prisoners, a lasting ceasefire and an Israeli withdrawal from Gaza. Talks mediated by the US, Egypt and Qatar have been deadlocked for months. Hamas started the war with its attack on southern Israel on October 7, 2023, when Palestinian militants killed around 1,200 people, mostly civilians, and took another 251 hostage. They still hold 55 hostages, fewer than half of them alive, after most of the rest were released in ceasefire agreements or other deals. Israel's military campaign has killed more than 54,800 Palestinians, according to Gaza's Health Ministry. It says women and children make up most of the dead, but doesn't say how many civilians or combatants were killed. Israel says it has killed more than 20,000 militants, without providing evidence. The war has destroyed vast areas of Gaza and displaced around 90% of its population. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
